Cover Image
Market Research Report
Product code 
1075568

Gene Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Published: | Transparency Market Research | 106 Pages | Delivery time: 1-2 business days

Price

Back to Top
Gene Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028
Published: March 31, 2022
Transparency Market Research
Content info: 106 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

Gene Therapy Market - Scope of Report

TMR's report on the global gene therapy market studies the past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global gene therapy market for the period 2017-2028, considering 2020 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global gene therapy market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global gene therapy market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global gene therapy market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global gene therapy market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global gene therapy market.

The report delves into the competitive landscape of the global gene therapy market. Key players operating in the global gene therapy market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global gene therapy market that have been profiled in this report.

Research Methodology

A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global gene therapy market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global gene therapy market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR's study on the gene therapy market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the gene therapy market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global gene therapy market with accuracy. The study also uses the top-down approach to assess the revenue for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR's estimates on future prospects of the global gene therapy market more reliably and accurately.

Product Code: TMRGL1838

Table of Contents

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Gene Therapy Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Gene Therapy Market Analysis and Forecast, 2018-2030
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Regulatory Scenario by Region/globally
  • 5.3. Key Industry Events (Mergers, Acquisitions, Partnerships, etc.)
  • 5.4. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)

6. Global Gene Therapy Market Analysis and Forecast, by Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Product, 2018-2030
    • 6.3.1. Yescarta
    • 6.3.2. Kymriah
    • 6.3.3. Luxturna
    • 6.3.4. Strimvelis
    • 6.3.5. Gendicine
    • 6.3.6. Others
  • 6.4. Market Attractiveness Analysis, by Product

7. Global Gene Therapy Market Analysis and Forecast, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Application, 2018-2030
    • 7.3.1. Ophthalmology
    • 7.3.2. Oncology
    • 7.3.3. Adenosine Deaminase-Deficient Severe Combined Immunodeficiency (ADA-SCID)
  • 7.4. Market Attractiveness Analysis, by Application

8. Global Gene Therapy Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast, by Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness Analysis, by Region

9. North America Global Gene Therapy Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast, by Product, 2018-2030
    • 9.2.1. Yescarta
    • 9.2.2. Kymriah
    • 9.2.3. Luxturna
    • 9.2.4. Strimvelis
    • 9.2.5. Gendicine
    • 9.2.6. Others
  • 9.3. Market Value Forecast, by Application, 2018-2030
    • 9.3.1. Ophthalmology
    • 9.3.2. Oncology
    • 9.3.3. Adenosine Deaminase-Deficient Severe Combined Immunodeficiency (ADA-SCID)
  • 9.4. Market Value Forecast, by Country, 2018-2030
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Product
    • 9.5.2. By Application
    • 9.5.3. By Country

10. Europe Global Gene Therapy Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product, 2018-2030
    • 10.2.1. Yescarta
    • 10.2.2. Kymriah
    • 10.2.3. Luxturna
    • 10.2.4. Strimvelis
    • 10.2.5. Gendicine
    • 10.2.6. Others
  • 10.3. Market Value Forecast, by Application, 2018-2030
    • 10.3.1. Ophthalmology
    • 10.3.2. Oncology
    • 10.3.3. Adenosine Deaminase-Deficient Severe Combined Immunodeficiency (ADA-SCID)
  • 10.4. Market Value Forecast, by Country, 2018-2030
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Spain
    • 10.4.5. Italy
    • 10.4.6. Rest of Europe
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Product
    • 10.5.2. By Application
    • 10.5.3. By Country

11. Asia Pacific Global Gene Therapy Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product, 2018-2030
    • 11.2.1. Yescarta
    • 11.2.2. Kymriah
    • 11.2.3. Luxturna
    • 11.2.4. Strimvelis
    • 11.2.5. Gendicine
    • 11.2.6. Others
  • 11.3. Market Value Forecast, by Application, 2018-2030
    • 11.3.1. Ophthalmology
    • 11.3.2. Oncology
    • 11.3.3. Adenosine Deaminase-Deficient Severe Combined Immunodeficiency (ADA-SCID)
  • 11.4. Market Value Forecast, by Country, 2018-2030
    • 11.4.1. China
    • 11.4.2. Japan
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Product
    • 11.5.2. By Application
    • 11.5.3. By Country

12. Latin America Global Gene Therapy Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product, 2018-2030
    • 12.2.1. Yescarta
    • 12.2.2. Kymriah
    • 12.2.3. Luxturna
    • 12.2.4. Strimvelis
    • 12.2.5. Gendicine
    • 12.2.6. Others
  • 12.3. Market Value Forecast, by Application, 2018-2030
    • 12.3.1. Ophthalmology
    • 12.3.2. Oncology
    • 12.3.3. Adenosine Deaminase-Deficient Severe Combined Immunodeficiency (ADA-SCID)
  • 12.4. Market Value Forecast, by Country, 2018-2030
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Product
    • 12.5.2. By Application
    • 12.5.3. By Country

13. Middle East & Africa Global Gene Therapy Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product, 2018-2030
    • 13.2.1. Yescarta
    • 13.2.2. Kymriah
    • 13.2.3. Luxturna
    • 13.2.4. Strimvelis
    • 13.2.5. Gendicine
    • 13.2.6. Others
  • 13.3. Market Value Forecast, by Application, 2018-2030
    • 13.3.1. Ophthalmology
    • 13.3.2. Oncology
    • 13.3.3. Adenosine Deaminase-Deficient Severe Combined Immunodeficiency (ADA-SCID)
  • 13.4. Market Value Forecast, by Country, 2018-2030
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Product
    • 13.5.2. By Application
    • 13.5.3. By Country

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (by tier and size of companies)
  • 14.2. Company Profiles
    • 14.2.1. Novartis AG
      • 14.2.1.1. Company Overview (HQ, Business Segments, Employee Strengths)
      • 14.2.1.2. Financial Overview
      • 14.2.1.3. Product Portfolio
      • 14.2.1.4. SWOT Analysis
      • 14.2.1.5. Strategic Overview
    • 14.2.2. Orchard Therapeutics Limited
      • 14.2.2.1. Company Overview (HQ, Business Segments, Employee Strengths)
      • 14.2.2.2. Financial Overview
      • 14.2.2.3. Product Portfolio
      • 14.2.2.4. SWOT Analysis
      • 14.2.2.5. Strategic Overview
    • 14.2.3. Celgene Corporation
      • 14.2.3.1. Company Overview (HQ, Business Segments, Employee Strengths)
      • 14.2.3.2. Financial Overview
      • 14.2.3.3. Product Portfolio
      • 14.2.3.4. SWOT Analysis
      • 14.2.3.5. Strategic Overview
    • 14.2.4. Spark Therapeutics, Inc.
      • 14.2.4.1. Company Overview (HQ, Business Segments, Employee Strengths)
      • 14.2.4.2. Financial Overview
      • 14.2.4.3. Product Portfolio
      • 14.2.4.4. SWOT Analysis
      • 14.2.4.5. Strategic Overview
    • 14.2.5. Gilead Sciences, Inc.
      • 14.2.5.1. Company Overview (HQ, Business Segments, Employee Strengths)
      • 14.2.5.2. Financial Overview
      • 14.2.5.3. Product Portfolio
      • 14.2.5.4. SWOT Analysis
      • 14.2.5.5. Strategic Overview
    • 14.2.6. Sibiono GeneTech Co. Ltd.
      • 14.2.6.1. Company Overview (HQ, Business Segments, Employee Strengths)
      • 14.2.6.2. Financial Overview
      • 14.2.6.3. Product Portfolio
      • 14.2.6.4. SWOT Analysis
      • 14.2.6.5. Strategic Overview
    • 14.2.7. Other prominent players
      • 14.2.7.1. Company Overview (HQ, Business Segments, Employee Strengths)
      • 14.2.7.2. Financial Overview
      • 14.2.7.3. Product Portfolio
      • 14.2.7.4. SWOT Analysis
      • 14.2.7.5. Strategic Overview

List of Table

  • Table 01: Global Gene Therapy Market Value (US$ Mn) Forecast, by Product, 2017-2028
  • Table 02: Global Gene Therapy Market Value (US$ Mn) Forecast, by Applications, 2017-2028
  • Table 03: Global Gene Therapy Market Value (US$ Mn) Forecast, by Region, 2017-2028
  • Table 04: North America Gene Therapy Market Value (US$ Mn) Forecast, by Product,2017-2028
  • Table 05: North America Gene Therapy Market Value (US$ Mn) Forecast, by Applications, 2017-2028
  • Table 06: North America Gene Therapy Market Value (US$ Mn) Forecast, by Country, 2017-2028
  • Table 07: Europe Gene Therapy Market Value (US$ Mn) Forecast, by Product,2017-2028
  • Table 08: Europe Gene Therapy Market Value (US$ Mn) Forecast, by Applications, 2017-2028
  • Table 09: Europe Gene Therapy Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017-2028
  • Table 10: Asia Pacific Gene Therapy Market Value (US$ Mn) Forecast, by Product,2017-2028
  • Table 11: Asia Pacific Gene Therapy Market Value (US$ Mn) Forecast, by Applications, 2017-2028
  • Table 12: Asia Pacific Gene Therapy Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017-2028
  • Table 13: Latin America Gene Therapy Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 14: Latin America Gene Therapy Market Value (US$ Mn) Forecast, by Applications, 2017-2028
  • Table 15: Latin America Gene Therapy Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017-2028
  • Table 16: Middle East & Africa Gene Therapy Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 17: Middle East & Africa Gene Therapy Market Value (US$ Mn) Forecast, by Applications, 2017-2028
  • Table 18: Middle East & Africa Gene Therapy Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017-2028

List of Figure

  • Figure 01: Global Gene Therapy Market Value (US$ Mn) Forecast, 2017-2028
  • Figure 02: Gene Therapy Market Value Share, by Product, 2020
  • Figure 03: Gene Therapy Market Value Share, by Applications - Use, 2020
  • Figure 04: Global Gene Therapy Market Value Share Analysis, by Product, 2020 and 2028
  • Figure 05: Global Gene Therapy Market Attractiveness Analysis, by Product, 2017-2028
  • Figure 06: Global Gene Therapy Market Value (US$ Mn), by Yescarta, 2017-2028
  • Figure 07: Global Gene Therapy Market Value (US$ Mn), by Kymriah, 2017-2028
  • Figure 08: Global Gene Therapy Market Value (US$ Mn), by Luxturna, 2017-2028
  • Figure 09: Global Gene Therapy Market Value (US$ Mn), by Strimvelis, 2017-2028
  • Figure 10: Global Gene Therapy Market Value (US$ Mn), by Gendicine, 2017-2028
  • Figure 11: Global Gene Therapy Market Value Share Analysis, by Applications, 2020 and 2028
  • Figure 12: Global Gene Therapy Market Attractiveness Analysis, by Applications, 2017-2028
  • Figure 13: Global Gene Therapy Market Value (US$ Mn), by Ophthalmology, 2017-2028
  • Figure 14: Global Gene Therapy Market Value (US$ Mn), by Oncology, 2017-2028
  • Figure 15: Global Gene Therapy Market Value (US$ Mn), by Adenosine Deaminase-Deficient Severe Combined Immunodeficiency (ADA-SCID), 2017-2028
  • Figure 16: Global Gene Therapy Market Value Share Analysis, by Region, 2020 and 2028
  • Figure 17: Global Gene Therapy Market Attractiveness Analysis, by Region, 2017-2028
  • Figure 18: North America Gene Therapy Market Value (US$ Mn) Forecast, 2017-2028
  • Figure 19: North America Gene Therapy Market Value Share Analysis, Product, 2020 and 2028
  • Figure 20: North America Gene Therapy Market Attractiveness Analysis, by Product, 2017-2028
  • Figure 21: North America Gene Therapy Market Value Share Analysis, by Applications, 2020 and 2028
  • Figure 22: North America Gene Therapy Market Attractiveness Analysis, by Applications, 2017-2028
  • Figure 23: North America Gene Therapy Market Value Share Analysis, by Country, 2020 and 2028
  • Figure 24: North America Gene Therapy Market Attractiveness Analysis, by Country, 2017-2028
  • Figure 25: Europe Gene Therapy Market Value (US$ Mn) Forecast, 2017-2028
  • Figure 26: Europe Gene Therapy Market Value Share Analysis, by Product, 2020 and 2028
  • Figure 27: Europe Gene Therapy Market Attractiveness Analysis, by Product, 2017-2028
  • Figure 28: Europe Gene Therapy Market Value Share Analysis, by Applications, 2020 and 2028
  • Figure 29: Europe Gene Therapy Market Attractiveness Analysis, by Applications, 2017-2028
  • Figure 30: Europe Gene Therapy Market Value Share Analysis, by Country/Sub-Region, 2020 and 2028
  • Figure 31: Europe Gene Therapy Market Attractiveness Analysis, by Country/Sub-Region, 2017-2028
  • Figure 32: Asia Pacific Gene Therapy Market Value (US$ Mn) Forecast, 2017-2028
  • Figure 33: Asia Pacific Gene Therapy Market Value Share Analysis, by Product, 2020 and 2028
  • Figure 34: Asia Pacific Gene Therapy Market Attractiveness Analysis, by Product, 2017-2028
  • Figure 35: Asia Pacific Gene Therapy Market Value Share Analysis, by Applications , 2020 and 2028
  • Figure 36: Asia Pacific Gene Therapy Market Attractiveness Analysis, by Applications, 2017-2028
  • Figure 37: Asia Pacific Gene Therapy Market Value Share Analysis, by Country/Sub-Region, 2020 and 2028
  • Figure 38: Asia Pacific Gene Therapy Market Attractiveness Analysis, by Country/Sub-Region, 2017-2028
  • Figure 39: Latin America Gene Therapy Market Value (US$ Mn) Forecast, 2017-2028
  • Figure 40: Latin America Gene Therapy Market Value Share Analysis, by Product, 2020 and 2028
  • Figure 41: Latin America Gene Therapy Market Attractiveness Analysis, by Product, 2017-2028
  • Figure 42: Latin America Gene Therapy Market Value Share Analysis, by Applications, 2020 and 2028
  • Figure 43: Latin America Gene Therapy Market Attractiveness Analysis, by Applications, 2017-2028
  • Figure 43: Latin America Gene Therapy Market Value Share Analysis, by Country/Sub-Region, 2020 and 2028
  • Figure 44: Latin America Gene Therapy Market Attractiveness Analysis, by Country/Sub-Region, 2017-2028
  • Figure 45: Middle East & Africa Gene Therapy Market Value (US$ Mn) Forecast, 2017-2028
  • Figure 46: Middle East & Africa Gene Therapy Market Value Share Analysis, by Product, 2020 and 2028
  • Figure 47: Middle East & Africa Gene Therapy Market Attractiveness Analysis, by Product, 2017-2028
  • Figure 48: Middle East & Africa Gene Therapy Market Value Share Analysis, by Applications, 2020 and 2028
  • Figure 49: Middle East & Africa Gene Therapy Market Attractiveness Analysis, by Applications, 2017-2028
  • Figure 50: Middle East & Africa Gene Therapy Market Value Share Analysis, by Country/Sub-Region, 2020 and 2028
  • Figure 51: Middle East & Africa Gene Therapy Market Attractiveness Analysis, by Country/Sub-Region, 2017-2028